These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 37169680)

  • 1. Retraction notice to "MicroRNA-298 represses hepatocellular carcinoma progression by inhibiting CTNND1-mediated Wnt/β-catenin signaling" [Biomed. Pharmacother., vol. 106, October 2018, Pages 483-490].
    Cao N; Mu L; Yang W; Liu L; Liang L; Zhang H
    Biomed Pharmacother; 2023 Jul; 163():114747. PubMed ID: 37169680
    [No Abstract]   [Full Text] [Related]  

  • 2. RETRACTED: MicroRNA-298 represses hepatocellular carcinoma progression by inhibiting CTNND1-mediated Wnt/β-catenin signaling.
    Cao N; Mu L; Yang W; Liu L; Liang L; Zhang H
    Biomed Pharmacother; 2018 Oct; 106():483-490. PubMed ID: 29990836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retraction notice to "Amentoflavone suppresses hepatocellular carcinoma by repressing hexokinase 2 expression through inhibiting JAK2/STAT3 signaling" [Biomed Pharmacother. 107 (2018) 243-253].
    Liu B; Yu S
    Biomed Pharmacother; 2020 Oct; 130():110635. PubMed ID: 32843235
    [No Abstract]   [Full Text] [Related]  

  • 4. Retraction notice to "Inhibition of miR-31a-5p decreases inflammation by down-regulating IL-25 expression in human dermal fibroblast cells (CC-2511 cells) under hyperthermic stress via Wnt/β-catenin pathway" [Biomed. Pharmacother. 107 (2018) 24-33].
    Jiang L; Xue W; Wang Y
    Biomed Pharmacother; 2021 Oct; 142():112129. PubMed ID: 34507835
    [No Abstract]   [Full Text] [Related]  

  • 5. Overexpression of CTNND1 in hepatocellular carcinoma promotes carcinous characters through activation of Wnt/β-catenin signaling.
    Tang B; Tang F; Wang Z; Qi G; Liang X; Li B; Yuan S; Liu J; Yu S; He S
    J Exp Clin Cancer Res; 2016 May; 35(1):82. PubMed ID: 27193094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retraction notice to "MicroRNA-361-5p inhibits papillary thyroid carcinoma progression by targeting ROCK1" [Biomed. Pharmacother. 102 (2018) 988-995].
    Li R; Dong B; Wang Z; Jiang T; Chen G
    Biomed Pharmacother; 2023 Aug; 164():114723. PubMed ID: 37088668
    [No Abstract]   [Full Text] [Related]  

  • 7. Retraction notice to "LEF-1 gene silencing inhibits pulmonary vascular remodeling and occurrence of pulmonary arterial hypertension through the β-catenin signaling pathway" [Biomed. Pharmacother. 108 (2018) 817-827].
    Zhang XF; Yang Y; Yang XY; Tong Q
    Biomed Pharmacother; 2020 Aug; 128():110242. PubMed ID: 32482442
    [No Abstract]   [Full Text] [Related]  

  • 8. Retraction notice to "Physcion 8-O-β-glucopyranoside suppresses tumor growth of Hepatocellular carcinoma by downregulating PIM1" [Biomed. Pharmacother. 92 (2017) 451-458].
    Wang Q; Jiang Y; Guo R; Lv R; Liu T; Wei H; Ming H; Tian X
    Biomed Pharmacother; 2022 Feb; 146():112625. PubMed ID: 35031233
    [No Abstract]   [Full Text] [Related]  

  • 9. Retraction notice to " Ophiopogonin B induces the autophagy and apoptosis of colon cancer cells by activating JNK/c-Jun signaling pathway" [Biomed. Pharmacother. Volume 108, December 2018, Pages 1208-1215].
    Gao GY; Ma J; Lu P; Jiang X; Chang C
    Biomed Pharmacother; 2023 Jul; 163():114768. PubMed ID: 37169673
    [No Abstract]   [Full Text] [Related]  

  • 10. Circ_0075960 targets the miR-202-5p/CTNND1 axis to promote the growth and migration of endometrial carcinoma cells via regulating Wnt/β-catenin signaling activity.
    Nian Y; Li X; Ma J; Gao T; Liu D
    J Gynecol Oncol; 2023 Jan; 34(1):e11. PubMed ID: 36424704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retraction notice to "physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis" [Biomed. Pharmacother. 104 (2018) 28-35].
    Wang Q; Yi Y; Zhang J; Guo P; Xing Y; Wang Y; Qin F; Zeng Q
    Biomed Pharmacother; 2021 Feb; 134():111070. PubMed ID: 33383313
    [No Abstract]   [Full Text] [Related]  

  • 12. Retraction notice to "Long non-coding RNA LINC00460 promotes epithelial ovarian cancer progression by regulating microRNA-338-3p" [Biomed. Pharmacother. 108 (2018) 1022-1028].
    Liu X; Wen J; Wang H; Wang Y
    Biomed Pharmacother; 2022 Sep; 153():113354. PubMed ID: 35835664
    [No Abstract]   [Full Text] [Related]  

  • 13. Retraction notice to "Alkannin inhibits proliferation, migration and invasion of hepatocellular carcinoma cells via regulation of miR-92a" [Biomed. Pharmacother. 114 (2019) 108782].
    Sun B; Zhang J; Liu M; Guan L
    Biomed Pharmacother; 2022 Feb; 146():112626. PubMed ID: 35031232
    [No Abstract]   [Full Text] [Related]  

  • 14. Retraction notice to "miR-217 represses TGF-β1-induced airway smooth muscle cell proliferation and migration through targeting ZEB1 " [Biomed. Pharmacother. 108 (2018) 27-35].
    Gao Y; Wang B; Luo H; Zhang Q; Xu M
    Biomed Pharmacother; 2023 Sep; 165():114805. PubMed ID: 37183050
    [No Abstract]   [Full Text] [Related]  

  • 15. Retraction notice to "Effect of microRNA-129-5p targeting HMGB1-RAGE signaling pathway on revascularization in a collagenase-induced intracerebral hemorrhage rat model" [Biomed. Pharmacother. 93 (2017) 238-244].
    Ma XL; Li SY; Shang F
    Biomed Pharmacother; 2023 Nov; 167():115366. PubMed ID: 37802726
    [No Abstract]   [Full Text] [Related]  

  • 16. Retraction: Circ_0075960 targets the miR-202-5p/CTNND1 axis to promote the growth and migration of endometrial carcinoma cells via regulating Wnt/β-catenin signaling activity.
    Editorial Boards of the Journal of Gynecologic Oncology
    J Gynecol Oncol; 2023 Sep; 34(5):e83. PubMed ID: 37545362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retraction notice to: "MicroRNA-370 protects against myocardial ischemia/reperfusion injury in mice following sevoflurane anesthetic preconditioning through PLIN5-dependent PPAR signaling pathway" Biomed. Pharmacother. 113 (2019) 108697.
    Zhao YB; Zhao J; Zhang LJ; Shan RG; Sun ZZ; Wang K; Chen JQ; Mu JX
    Biomed Pharmacother; 2023 Oct; 166():114875. PubMed ID: 37353382
    [No Abstract]   [Full Text] [Related]  

  • 18. Retraction notice to "MicroRNA-30e promotes hepatocyte proliferation and inhibits apoptosis in cecal ligation and puncture-induced sepsis through the JAK/STAT signaling pathway by binding to FOSL2" [Biomed. Pharmacother. 104 (2018) 411-419].
    Ling L; Zhang SH; Zhi LD; Li H; Wen QK; Li G; Zhang WJ
    Biomed Pharmacother; 2023 Sep; 165():114767. PubMed ID: 37183051
    [No Abstract]   [Full Text] [Related]  

  • 19. Retraction notice to "Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor" [Biomed. Pharmacother. 104 (2018) 686-698].
    Feng K; Liu Y; Xu LJ; Zhao LF; Jia CW; Xu MY
    Biomed Pharmacother; 2023 Jun; 162():114552. PubMed ID: 36990893
    [No Abstract]   [Full Text] [Related]  

  • 20. Hsa_circ_0002577 promotes endometrial carcinoma progression via regulating miR-197/CTNND1 axis and activating Wnt/β-catenin pathway.
    Shen Q; He T; Yuan H
    Cell Cycle; 2019 Jun; 18(11):1229-1240. PubMed ID: 31081718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.